Get the ChemPriceHub app— track prices on the go. Membership syncs across app & web.
View plans
Privacy choicesWe use cookies to improve your experience
We use cookies and similar technologies to keep the site secure and understand traffic. Analytics cookies are optional and will stay off unless you choose to enable them. Read our Privacy Notice.
Always onSecurity, session continuity, and core site functionality.
OptionalAnalytics stays off until you explicitly accept or enable it.
Cookie Preferences
Manage your cookie preferences here. Essential cookies are always enabled so the site can function correctly. You can change your choice at any time via the "Cookie Settings" link in the footer. Read our Privacy Notice for full details.
Essential Cookies
Required for basic site functionality, including anti-spam protection and session management. Always active.
Analytics Cookies
Help us understand how visitors interact with the site. We use Google Analytics only when you accept analytics cookies. Disabling this will not affect essential functionality.
Quality control is becoming a differentiator. Buyers sourcing ampicillin for human injectable use should verify beta-lactamase stability data and impurity profiles, not just assay content. The shift toward combination products like ampicillin-sulbactam may erode plain ampicillin demand growth, so contract terms should account for potential oversupply in standard grades.
The enzyme versus chemical synthesis cost gap is narrowing as enzyme technology matures. Buyers should qualify multiple suppliers across both routes to maintain negotiating leverage. Also note that environmental compliance costs are rising for older chemical synthesis plants, which may accelerate closures and benefit enzyme-based producers with modern facilities.
The year-on-year drop in ampicillin sodium is notable. Watch capacity migration: Shandong Lukang's relocation project keeps ampicillin sodium at only 20 t/a while adding piperacillin and mezlocillin. This signals producers are reallocating sterile capacity toward higher-value penicillins, which could tighten ampicillin sodium supply in 2025-2026.